157 — Natural Beauty Bio-Technology Income Statement
0.000.00%
Last trade - 00:00- HK$961.01m
- HK$1.06bn
- HK$353.65m
Annual income statement for Natural Beauty Bio-Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 411 | 488 | 336 | 336 | 354 |
| Cost of Revenue | |||||
| Gross Profit | 240 | 306 | 189 | 200 | 202 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 400 | 438 | 355 | 340 | 451 |
| Operating Profit | 10.6 | 50.3 | -19.2 | -3.74 | -97.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 8.98 | 48.5 | -23.5 | -11.9 | -105 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 7.76 | 35.3 | -30.5 | -15.1 | -104 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 7.76 | 35.3 | -30.5 | -15.1 | -104 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 7.76 | 35.3 | -30.5 | -15.1 | -104 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.005 | 0.018 | -0.013 | -0.008 | -0.042 |
| Dividends per Share |